These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9420638)

  • 21. Palliation of heart failure.
    Davis MP; Albert NM; Young JB
    Am J Hosp Palliat Care; 2005; 22(3):211-22. PubMed ID: 15909784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-chamber pacemakers in the management of severe heart failure.
    Van Orden Wallace CJ
    Crit Care Nurse; 1998 Apr; 18(2):57-67. PubMed ID: 9708120
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure.
    Saxon LA; De Marco T
    J Am Coll Cardiol; 2001 Dec; 38(7):1971-3. PubMed ID: 11738302
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac resynchronization for asymptomatic or mildly symptomatic heart failure: a bridge too far?
    Leclercq C; Mabo P; Trochu JN
    J Am Coll Cardiol; 2008 Dec; 52(23):1844-1846. PubMed ID: 19038681
    [No Abstract]   [Full Text] [Related]  

  • 25. Why biventricular pacing might be of value in refractory heart failure?
    Leclercq C; Daubert JC
    Heart; 2000 Aug; 84(2):125-6. PubMed ID: 10908240
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluating quality of care for patients with heart failure.
    Krumholz HM; Baker DW; Ashton CM; Dunbar SB; Friesinger GC; Havranek EP; Hlatky MA; Konstam M; Ordin DL; Pina IL; Pitt B; Spertus JA
    Circulation; 2000 Mar; 101(12):E122-40. PubMed ID: 10736303
    [No Abstract]   [Full Text] [Related]  

  • 27. Do we understand who benefits from resynchronisation therapy?
    Breithardt OA; Claus P; Sutherland GR
    Eur Heart J; 2004 Apr; 25(7):535-6. PubMed ID: 15120047
    [No Abstract]   [Full Text] [Related]  

  • 28. Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely.
    Cleland JG; Tageldien A; Maarouf N; Hobson N
    Heart; 2008 Aug; 94(8):963-6. PubMed ID: 18625785
    [No Abstract]   [Full Text] [Related]  

  • 29. The good, the bad, and the ugly: Contemporary options for biventricular support.
    Joyce DL
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):536-7. PubMed ID: 26602261
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance.
    Al-Mohammad A; Mant J; Laramee P; Swain S;
    BMJ; 2010 Aug; 341():c4130. PubMed ID: 20739363
    [No Abstract]   [Full Text] [Related]  

  • 31. Images in cardiovascular medicine. Visualization of regional left ventricular mechanical delay by tissue synchronization imaging in heart failure patients with wide and narrow QRS complexes undergoing cardiac resynchronization therapy.
    Yu CM; Zhang Q; Fung JW
    Circulation; 2005 Aug; 112(7):e93-5. PubMed ID: 16103246
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of wasted energy is a key to predict positive response to cardiac resynchronization therapy: is strain imaging the answer?
    Oh JK; Vatury OM; Wang CL
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):159-61. PubMed ID: 23512777
    [No Abstract]   [Full Text] [Related]  

  • 33. RV electrical activation in heart failure during right, left, and biventricular pacing.
    Bernier M; Josephson ME
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):576-7. PubMed ID: 20541712
    [No Abstract]   [Full Text] [Related]  

  • 34. "Underestimation" of a left ventricular threshold.
    Ploux S; Thambo JB; Bordachar P
    Arch Cardiovasc Dis; 2011 Nov; 104(11):591-2. PubMed ID: 22117912
    [No Abstract]   [Full Text] [Related]  

  • 35. Adrenergic and cholinergic plasticity in heart failure.
    Fernandez SF; Canty JM
    Circ Res; 2015 May; 116(10):1639-42. PubMed ID: 25953921
    [No Abstract]   [Full Text] [Related]  

  • 36. III. Management of chronic heart failure. Foreword.
    Crawford MH
    Cardiol Clin; 2008 Feb; 26(1):xi. PubMed ID: 18312900
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathobiology of left ventricular dyssynchrony and resynchronization.
    Spragg DD; Kass DA
    Prog Cardiovasc Dis; 2006; 49(1):26-41. PubMed ID: 16867848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D; Marshall R; Soisson K
    Lippincotts Prim Care Pract; 1999; 3(3):316-32. PubMed ID: 10711133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remodeling in heart failure: from the left ventricle to service delivery.
    Japp AG; Pettit SJ
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):285-7. PubMed ID: 23469907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leads for cardiac resynchronization therapy: where and how many?
    Hof MJ; Maass AH
    Eur J Heart Fail; 2012 May; 14(5):459-60. PubMed ID: 22499545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.